Although the precise regulatory mechanism between phycocyanin and RIPK1 still needs further exploration, our work undoubtedly lays a theoretical basis on the potential treatment of NSCLC with marine functional products. The gene discussed is RIPK1; the disease is non-small cell lung carcinoma.